AG
AVNS icon

Advisor Group’s Avanos Medical AVNS Stock Holding History

Advisor Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$32K Sell
962
-87
-8% -$3.15K ﹤0.01% 3692
2019
Q3 		$39K Sell
1,049
-5,915
-85% -$226K ﹤0.01% 3552
2019
Q2 		$306K Sell
6,964
-731
-9% -$31.3K ﹤0.01% 1978
2019
Q1 		$329K Buy
7,695
+2,281
+42% +$102K ﹤0.01% 1895
2018
Q4 		$242K Buy
5,414
+2,120
+64% +$111K ﹤0.01% 1950
2018
Q3 		$225K Buy
3,294
+2,141
+186% +$138K ﹤0.01% 2065
2018
Q2 		$66K Sell
1,153
-159
-12% -$8.4K ﹤0.01% 2863
2018
Q1 		$60K Sell
1,312
-222
-14% -$10.5K ﹤0.01% 2923
2017
Q4 		$71K Buy
1,534
+656
+75% +$30.1K ﹤0.01% 2836
2017
Q3 		$40K Buy
878
+19
+2% +$811 ﹤0.01% 3092
2017
Q2 		$34K Buy
859
+339
+65% +$12.8K ﹤0.01% 3111
2017
Q1 		$20K Buy
520
+206
+66% +$8.03K ﹤0.01% 3360
2016
Q4 		$12K Sell
314
-5
-2% -$179 ﹤0.01% 3526
2016
Q3 		$11K Sell
319
-355
-53% -$12.4K ﹤0.01% 3496
2016
Q2 		$19K Buy
+674
New +$20.6K ﹤0.01% 3086

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Advisor Group's AVNS Position: Q4 2019 in Review

Advisor Group reduced its Avanos Medical (AVNS) stake by 8.3% in Q4 2019, selling an estimated $3.15K and leaving 962 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #3692.

Advisor Group first reported a position in AVNS in Q2 2016 and has held it in 15 quarters since. The position peaked at $329K in Q1 2019. 293 funds tracked by Wall St. Rank hold AVNS as of Q4 2019.

  • Advisor Group held 962 shares of Avanos Medical worth $32K as of Q4 2019.
  • Advisor Group sold 87 Avanos Medical shares in Q4 2019, an estimated $3.15K.
  • Avanos Medical made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3692 holding.
  • Advisor Group first reported a position in Avanos Medical in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Avanos Medical position peaked at $329K in Q1 2019.
  • 293 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.